Sharpepoint LLC Dexcom Inc Transaction History
Sharpepoint LLC
- $114 Billion
- Q1 2025
A detailed history of Sharpepoint LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sharpepoint LLC holds 3,705 shares of DXCM stock, worth $264,166. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,705
Previous 4,405
15.89%
Holding current value
$264,166
Previous $343 Million
22.89%
% of portfolio
0.23%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,083Shares Held
354MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.32 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.46 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.19 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.04 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.02 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...